Zhou, H. et al. (2010) Non-coding RNAs and their epigenetic regulatory mechanisms. Biol Cell 102, 645-655.

Yu XF, Zou J, Bao ZJ and Dong J. (2011) miR-93 suppresses proliferation and colonyformation of human colon cancer stem cells. World J Gastroenterol. 17(42):4711-4717.

Xiong Y, Zhang L, Holloway AK, Wu X, Su L and Kebebew E. (2011) MiR-886-3pregulates cell proliferation and migration, and is dysregulated in familial non-medullarythyroid cancer. PLoS One. 6(10):e24717.

Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi LJ, Zhou ZT and Jiang WW. (2012)Upregulation of miR-31* is negatively associated with recurrent/newly formed oralleukoplakia. PLoS One. 7(6):e38648.

Treppendahl, M.B. et al. (2012) Allelic methylation levels of the noncoding VTRNA2-1located on chromosome 5q31.1 predict outcome in AML. Blood 119, 206?216.

Tian, B. and Mathews, M.B. (2001) Functional characterization of and cooperationbetween the double-stranded RNA-binding motifs of the protein kinase PKR. J. Biol.Chem. 276, 9936?9944.

Takai D and Jones PA. (2002) Comprehensive analysis of CpG islands in humanchromosomes 21 and 22. Proc Natl Acad Sci USA. 99(6):3740-3745

Taft, R.J., Pheasant, M. and Mattick, J.S. (2007) The relationship between non-proteincodingDNA and eukaryotic complexity. BioEssays 29, 288?299.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, PaulovichA, Pomeroy SL, Golub TR, Lander ES and Mesirov JP. (2005) Gene set enrichmentanalysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci USA. 102(43):15545-15550.

Selvakumar T, Gjidoda A, Hovde SL and Henry RW. (2012) Regulation of human RNApolymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases. J BiolChem. 287(10):7039-7050.

Schmedt, C., Green, S.R., Manche, L., Taylor, D.R., Ma, Y. and Mathews, M.B. (1995)Functional characterization of the RNA-binding domain and motif of the double-strandedRNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249, 29?44.

Richards, E.J. (2006) Inherited epigenetic variation-revisiting soft inheritance. Nat.Rev. Genet. 7, 395?40165

Ponting, C.P., Oliver, P.L. and Reik, W. (2009) Evolution and functions of longnoncoding RNAs. Cell .136, 629?641.

Pillai MM, Yang X, Balakrishnan I, Bemis L and Torok- Storb B. (2010) MiR-886-3pdown regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One.5(12):e14304.

Patel, R.C., Stanton, P. and Sen, G.C. (1996) Specific mutations near the amino terminusof double-stranded RNA-dependent protein kinase (PKR) differentially affect its doublestrandedRNA binding and dimerization properties. J. Biol. Chem. 271, 25657?25663.

Patel, R.C. and Sen, G.C. (1992) Identification of the double-stranded RNA-bindingdomain of the human interferon-inducible protein kinase. J. Biol. Chem. 267, 7671?7676.

Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, Chandler KJ, Cassiday PA,Nelson CA, Hagedorn CH, Graves BJ and Cairns BR. (2010) Human RNA polymeraseIII transcriptomes and relationships to Pol II promoter chromatin and enhancer-bindingfactors. Nat Struct Mol Biol. 17(5):620-628.66

Nordentoft I, Birkenkamp-Demtroder K, Agerbaek M, Theodorescu D, Ostenfeld MS,Hartmann A, Borre M, Orntoft TF and Dyrskjot L. (2012) miRNAs associated withchemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genomics.5:40.

Nandy, C.; Mrazek, J.; Stoiber, H.; Grasser, F.A.; Huttenhofer, A.; Polacek, N. (2009)Epstein-barr virus-induced expression of a novel human vault RNA. J. Mol. Biol. 388,776?784.

Nanduri, S., Rahman, F., Williams, B.R. and Qin, J. (2000) A dynamically tuned double68stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J.19, 5567?5574.

Nallagatla, S.R., Toroney, R. and Bevilacqua, P.C. (2011) Regulation of innate immunitythrough RNA structure and the protein kinase PKR. Curr. Opin. Struct. Biol. 21, 119?127.

Miller AD, Curran T and Verma IM. (1984) c-fos protein can induce cellulartransformation: a novel mechanism of activation of a cellular oncogene. Cell. 36(1):51-6960.

McCormack, S.J., Ortega, L.G., Doohan, J.P. and Samuel, C.E. (1994) Mechanism ofinterferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR)is sufficient to mediate RNA-binding activity. Virology 198, 92?99.

Mattick, J.S., Amaral, P.P., Dinger, M.E., Mercer, T.R., and Mehler, M.F. (2009) RNA regulation of epigenetic processes. Bioessays 31, 51-59.

Mattick, J.S. and Makunin, I.V. (2005) Small regulatory RNAs in mammals. Hum.Mol. Genet. 14, R121?R132

Mattick, J.S. (2004) The hidden genetic program of complex organisms. Sci. Am. 291:60-7.

Marshall L and White RJ. (2008) Non-coding RNA production by RNA polymerase III isimplicated in cancer. Nat Rev Cancer. 8(12):911-914.

Marlink KL, Bacon KD, Sheppard BC, Ashktorab H, Smoot DT, Cover TL, Deveney CWand Rutten MJ. (2003) Effects of Helicobacter pylori on intracellular Ca2+ signaling innormal human gastric mucous epithelial cells. Am J Physiol Gastrointest Liver Physiol.285(1):G163-176.

Mancini-Dinardo, D., Steele, S.J., Levorse, J.M., Ingram, R.S. and Tilghman, S.M.(2006) Elongation of the Kcnq1ot1 transcript is required for genomic imprinting ofneighboring genes. Genes Dev. 20, 1268?1282

Malmberg, K.J.; Ljunggren, H.G. (2006) Escape from immune- and nonimmunemediatedtumor surveillance. Semin. Cancer Biol. 16, 16?31.

Mahishi LH, Hart RP, Lynch DR and Ratan RR. (2012) miR-886- 3p levels are elevatedin Friedreich ataxia. J Neurosci. 32(27):9369-9373.

Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R,Barreca A, Pellegrino E, Spaccarotella E, Lachel CM, Kucuk C, Jiang CS, Hu X,Bhagavathi S, et al. (2013) MicroRNA expression profiling identifies molecularsignatures associated with anaplastic large cell lymphoma. Blood. 122(12):2083-2092.

Li JH, Xiao X, Zhang YN, Wang YM, Feng LM, Wu YM and Zhang YX. (2011)MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in humancervical carcinoma cells. Gynecol Oncol. 120(1):145-151.

Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, Bang JY, Park HS,Leelayuwat C and Lee YS. (2011) Precursor miR-886, a novel noncoding RNA repressedin cancer, associates with PKR and modulates its activity. RNA. 17(6):1076-1089.

Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, GolombHM and Rowley JD. (1986) Clinical and cytogenetic correlations in 63 patients withtherapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: furtherevidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol.4(3):325- 345.

Landgraf, P.; Rusu, M.; Sheridan, R.; Sewer, A.; Iovino, N.; Aravin, A.; Pfeffer, S.; Rice,A.; Kamphorst, A.O.; Landthaler, M.; et al. (2007) A mammalian microRNA expressionatlas based on small RNA library sequencing. Cell. 129, 1401?1414.

Kunkeaw N, Jeon SH, Lee K, Johnson BH, Tanasanvimon S, Javle M, Pairojkul C,Chamgramol Y, Wongfieng W, Gong B, Leelayuwat C and Lee YS. (2013) Celldeath/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway incholangiocarcinoma. Oncogene. 32(32):3722-3731.

Klein, G.; Klein, E. (1997) Immune surveillance against virus-induced tumors andnonrejectability of spontaneous tumors: Contrasting consequences of host versus tumorevolution. Proc. Natl. Acad. Sci. USA. 74, 2121?2125.

Klein, G. (2004) Cancer, apoptosis, and nonimmune surveillance. Cell Death. Differ. 11,7113?17.

Kim, I., Liu, C.W. and Puglisi, J.D. (2006) Specific recognition of HIV TAR RNA by thedsRNA binding domains (dsRBD1?dsRBD2) of PKR. J. Mol. Biol. 358, 430?442.

Kim SY and Volsky DJ. (2005) PAGE: parametric analysis of gene set enrichment. BMCBioinformatics. 6:144.

Jeon SH, Lee K, Lee KS, Kunkeaw N, Johnson BH, Holthauzen LM, Gong B,Leelayuwat C and Lee YS. (2012) Characterization of the direct physical interaction ofnc886, a cellular non-coding RNA, and PKR. FEBS Lett. 586(19):3477-3484.

Jeon SH, Johnson BH and Lee YS. (2012) A tumor surveillance model: a non-codingRNA senses neoplastic cells and its protein partner signals cell death. Int J Mol Sci.13(10):13134-13139.

Hoglund, P. (2006) DNA damage and tumor surveillance: One trigger for two pathways.Sci. STKE 2006. doi:10.1126/stke.3172006pe2.

Heyn H and Esteller M. (2012) DNA methylation profiling in the clinic: applications andchallenges. Nat Rev Genet. 13(10):679-692.

Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQand Peng ZH. (2012) Identification of recurrence-related microRNAs in hepatocellularcarcinoma following liver transplantation. Mol Oncol. 6(4):445-457.70

Glickman, J.N., Howe, J.G. and Steitz, J.A. (1988) Structural analyses of EBER1 andEBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol.62, 902?911

Gardiner-Garden M and Frommer M. (1987) CpG islands in vertebrate genomes. J MolBiol. 196(2):261-282.

Garcia, M.A., Meurs, E.F. and Esteban, M. (2007) The dsRNA protein kinase PKR: virusand cell control. Biochimie 89, 799?811.

Gao W, Shen H, Liu L, Xu J and Shu Y. (2011) MiR-21 overexpression in human primarysquamous cell lung carcinoma is associated with poor patient prognosis. J Cancer ResClin Oncol. 137(4):557-566.

Fairman J, Chumakov I, Chinault AC, Nowell PC and Nagarajan L. (1995) Physicalmapping of the minimal region of loss in 5q- chromosome. Proc Natl Acad Sci USA.92(16):7406-7410.

Davis, S. and Watson, J.C. (1996) In vitro activation of the interferon-induced, doublestrandedRNA-dependent protein kinase PKR by RNA from the 3 un-translated regionsof human alpha-tropomyosin. Proc. Natl. Acad. Sci. U S A 93, 508?513.

Costa, F.F. (2008) Non-coding RNAs, epigenetics and complexity. Gene 410, 9?17.

Cole, J.L. (2007) Activation of PKR: an open and shut case? Trends Biochem. Sci.32, 57?6762.

Clarke, P.A. and Mathews, M.B. (1995) Interactions between the double-stranded RNAbinding motif and RNA: definition of the binding site for the interferon-induced proteinkinase DAI (PKR) on adenovirus VA RNA. RNA 1, 7?20.

Clark, S.J. (2007) Action at a distance: epigenetic silencing of large chromosomalregions in carcinogenesis. Hum. Mol. Genet. 16, R88?R95

Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL,Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ and Guegler KJ. (2005) Real-timequantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33(20):e179.

Cao J, Song Y, Bi N, Shen J, Liu W, Fan J, Sun G, Tong T, He J, Shi Y, Zhang X, Lu N,He Y, Zhang H, Ma K, Luo X, et al. (2013) DNA methylation-mediated repression ofmiR-886- 3p predicts poor outcome of human small cell lung cancer. Cancer Res.73(11):3326-3335.

Canella D, Praz V, Reina JH, Cousin P and Hernandez N. (2010) Defining the RNApolymerase III transcriptome: Genome-wide localization of the RNA polymerase IIItranscription machinery in human cells. Genome Res. 20(6):710- 721.

Bevilacqua, P.C. and Cech, T.R. (1996) Minor-groove recognition of doublestrandedRNA by the double-stranded RNA-binding domain from the RNA-activated proteinkinase PKR. Biochemistry 35, 9983?9994.

Besser D, Gotz F, Schulze-Forster K, Wagner H, Kroger H and Simon D. (1990) DNAmethylation inhibits transcription by RNA polymerase III of a tRNA gene, but not of a 5SrRNA gene. FEBS Lett. 269(2):358-362.

Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281?97

Banati F, Koroknai A, Salamon D, Takacs M, Minarovits- Kormuta S, Wolf H, Niller HHand Minarovits J. (2008) CpG-methylation silences the activity of the RNA polymeraseIII transcribed EBER-1 promoter of Epstein-Barr virus. FEBS Lett. 582(5):705-709.

Asaoka T, Sotolongo B, Island ER, Tryphonopoulos P, Selvaggi G, Moon J, Tekin A,Amador A, Levi DM, Garcia J, Smith L, Nishida S, Weppler D, Tzakis AG and Ruiz P.(2012) MicroRNA signature of intestinal acute cellular rejection in formalin-fixedparaffin-embedded mucosal biopsies. Am J Transplant. 12(2):458-468.

Aparicio, S., Chapman, J., Stupka, E., Putnam, N., Chia, J.M., Dehal,P., Christoffels, A., Rash, S., Hoon, S., Smit, A. et al. (2002) Whole-genome shotgun assemblyand analysis of the genome of Fugu rubripes. Science 297, 1301?1310.

Ahmad, M.K. (2013) Epigenetic regulation by large non-coding RNAs. Peanuts 10,4-6.